The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Sigma Corporation, In the Matter of
The FTC filed separate complaints against the three largest U.S. suppliers of ductile iron pipe fittings, which are used in municipal water systems around the United States. The FTC charged that the three companies, McWane, Inc., Star Pipe Products, Ltd., and Sigma Corporation, illegally conspired to set and maintain prices for pipe fittings, and that McWane illegally maintained its monopoly power in the market for U.S.-made pipe fittings by implementing an exclusive dealing policy. Sigma settled the FTC's charges prior to litigation (final order dated Feb. 27, 2012); Star settled soon after (final order dated May 8, 2012). The complaint against McWane was heard before an administrative law judge and later appealed to the Commission; see Docket No. 9351.
20120536: Oracle Corporation; Taleo Corporation
1202013 Informal Interpretation
1202013 Informal Interpretation
1202014 Informal Interpretation
1202014 Informal Interpretation
20120529: Fidelity National Financial, Inc.; O'Charley's Inc.
20120524: Roger S. Penske; Roger S. Penske
20120523: KRG Capital Fund IV, L.P.; Frontenac VIII Limited Partnership
20120522: Innovative Interfaces Holdings Ltd.; Gerald M. Kline
20120502: CVS Caremark Corporation; Health Net, Inc.
JGRD, Inc., also d/b/a Voiceblaze.com and VoiceBlaze, et al.
20120469: Raymond James Financial, Inc.; Regions Financial Corp.
20120338: TE Connectivity Ltd.; Wendel SA
20120519: Molibdenos y Metales S.A.; Molycorp, Inc.
1202011 Informal Interpretation
1202011 Informal Interpretation
Omnicare, Inc., a corporation, In the Matter of
The Commission issued a complaint to block Omnicare, Inc.'s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and others. In its complaint, the FTC charges that a deal combining Omnicare and PharMerica would significantly increase Omnicare's already substantial bargaining leverage by dramatically increasing the number of skilled nursing facilities, known as SNFs, that receive long-term care pharmacy services from the company. Due to its substantial market share, the FTC alleges that the combined firm likely would be a "must have" for Medicare Part D prescription drug plans, which are responsible for providing subsidized prescription drug benefit coverage for most SNF residents and other Medicare beneficiaries. On 2/23/2012, the FTC dismissed the complaint in light of Omnicare's decision to abandon the proposed transaction.